Teva Pharmaceuticals USA, Inc recalls
16 recalls.
- Metoclopramide Tablets recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported October 21, 2026 · Presence of Foreign Tablets/Capsules - traZODone Hydrochloride Tablets recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported September 9, 2026 · Presence of Foreign Tablets/Capsules - Octreotide Acetate for Injectable Suspension recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported May 13, 2026 · Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract... - Claravis recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported April 29, 2026 · Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin - Clonidine Transdermal System recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported April 15, 2026 · CGMP Deviations: use of an unapproved raw material - Clonidine Transdermal System recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported April 15, 2026 · CGMP Deviations: use of an unapproved raw material - Clonidine Transdermal System recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported April 15, 2026 · CGMP Deviations: use of an unapproved raw material - Isotretinoin Capsules recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported April 15, 2026 · Superpotent and Subpotent - Isotretinoin Capsules recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported April 15, 2026 · Superpotent and Subpotent - Octreotide Acetate for Injectable Suspension recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported April 1, 2026 · Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract... - Octreotide Acetate for Injectable Suspension recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported April 1, 2026 · Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract... - Octreotide Acetate for Injectable Suspension recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported April 1, 2026 · Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract... - Metoprolol Succinate Extended-Release Tablets recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported March 11, 2026 · Failed Dissolution Specifications - Metoprolol Succinate Extended-Release Tablets recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported March 11, 2026 · Failed Dissolution Specifications - Metoprolol Succinate Extended-Release Tablets recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported March 11, 2026 · Failed Dissolution Specifications - Metoprolol Succinate Extended-Release Tablets recall (Teva Pharmaceuticals USA, Inc)
DrugClass IIReported March 11, 2026 · Failed Dissolution Specifications